Emergency coronary revascularization using polytetrafluoroethylene conduits in a patient in cardiogenic shock.
There is growing awareness that a particular subset of patients with coronary artery disease who need surgical revascularization do not have autologous vein or internal mammary artery available or surgically applicable. The polytetrafluoroethylene graft has had limited use in aortocoronary bypass procedures. We describe a case of cardiogenic shock secondary to severe coronary artery disease and aortic stenosis, where the use of this synthetic graft contributed to a successful outcome. Angiographic patency was documented at 3 months follow-up. Our experience, plus a review of the literature, supports the use of polytetrafluoroethylene grafts during aortocoronary artery bypass to salvage infarcting or ischemic myocardium, when traditional autologous bypass conduits are not available or applicable.
Hartman
A R
AR
Division of Cardiac Surgery, State University of New York, Stony Brook 11794.
Vlay
S C
SC
Dervan
J P
JP
Lawson
W E
WE
Mannisi
J
J
Anagnostopoulos
C E
CE
D000368:Aged; D001024:Aortic Valve Stenosis / Q000150:complications / Q000601:surgery; D001807:Blood Vessel Prosthesis; D001026:Coronary Artery Bypass / Q000379:methods*; D004630:Emergencies; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000601:surgery; D011138:Polytetrafluoroethylene; D012770:Shock, Cardiogenic / Q000209:etiology / Q000601:surgery*
D011138:Polytetrafluoroethylene